Nuclear Medicine

Uzm. Dr. Fatma Arzu Görtan

Doctor and researcher Ankara Bilkent Şehir Hastanesi Ankara
Thyroid Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyNuclear Medicinesaglik.gov.trFrom source
  • InstitutionAnkara Bilkent Şehir Hastanesisaglik.gov.trFrom source
  • Area of workThyroid NeoplasmsExtracted from 2 publications · Model version —From source
  • Publications15 publicationsEurope PMC, OpenAlex, ORCIDFrom source
  • ORCID0000-0001-8991-0075ORCIDFrom source
  • Last synchronised7 November 2026 00:02https://ankarasehir.saglik.gov.tr/TR-331820/nukleer-tip-klinigi-doktorlarimiz.html#fatma-arzu-gortansaglik.gov.tr

Scientific work

Publications on Thyroid Neoplasms

15 publications

  1. Dilemma on Pancreatic Uncinate Process Uptake on Ga68-DOTA Peptide PET/CT in Pediatric Neuroblastoma: Physiologic or Metastases?

    Current radiopharmaceuticals, 2025

    DOI 10.2174/0118744710226018250206105536 PMID 39966364 Open-access full textSource: Europe PMC

  2. Optimization of SUV with Changing the Dose Amount in F18-FDG PET/CT of Pediatric Lymphoma Patients

    Current Radiopharmaceuticals, 2022

    DOI 10.2174/1874471016666221118114726 PMID 36411582 Source: OpenAlex

  3. Dosimetric approach to 131I ablation therapy for the differentiated thyroid cancer.

    PubMed, 2022

    DOI 10.1967/s002449912514 PMID 36507882 Source: OpenAlex

  4. Tiroid Bezi Hastalıkları ve Cerrahisi

    Akademisyen Kitabevi eBooks, 2022

    DOI 10.37609/akya.1655 Source: OpenAlex

  5. Dosimetric approach to 131I remnant ablation in differentiated thyroid cancer

    Physica Medica, 2021

    DOI 10.1016/s1120-1797(22)00059-x Source: OpenAlex

  6. Assessment of volumetric parameters derived from 68Ga-PSMA PET/CT in prostate cancer patients with biochemical recurrence: an institutional experience

    Nuclear Medicine Communications, 2021

    DOI 10.1097/mnm.0000000000001459 PMID 34284438 9 citations (Europe PMC) Source: ORCID

  7. Diferansiye Tiroid Kanseri 131-I Ablasyon Tedavisinde Dozimetrik Yaklaşım

    AYBU AVESIS, 2020

    Source: OpenAlex

  8. Prostat Kanseri Hastalarında Ga-68 PSMA PET/BT Tekstür Özellikleri ile Histopatolojik Parametrelerin İlişkisi

    AYBU AVESIS, 2020

    Source: OpenAlex

  9. Prostat Kanserinde Total PSA Değeri ile Ga-68 PSMA PET/ BT’den Elde Edilen Volümetrik Ölçümlerin Korelasyon Düzeyi

    AYBU AVESIS, 2020

    Source: OpenAlex

  10. Usefulness of 18F-FDG PET/CT in Cutaneous Melanoma Patients with Negative Sentinel Lymph Nodes and High Clark Levels

    Molecular Imaging and Radionuclide Therapy, 2018

    DOI 10.4274/mirt.70783 PMID 29889028 4 citations (Europe PMC) Open-access full textSource: OpenAlex

View all 15 publications